Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is also engaged in the trading of industrial solvents and chemicals. The firm is manufacturing intermediates, which include Mono Methyl Urea, Die Methyl Urea, Ortho Para Nitro Anisole, 2 Bromomethyl 1,3 Dioxalane and Uracile. The Company’s API includes Metformin Hydrochloric Acid (HCL), Mefenamic Acid and Doxophylline. The firm's chemical and solvents include aromatics chemicals, chemical acid, chloralkaline, industrial alcohols, industrial ketones, glycols and glycol ethers, fiber intermediates, industrial amines, acetates and esters, industrial oleochemicals, chlorinated solvents, industrial intermediates, industrial olefines, industrial phosphates, industrial fertilizers, industrial monomers and industrial chemicals.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.